JP Morgan office in Manhattan, New York. Photo: Ryland West/ALM

After getting sued on March 14 by a former employee who says an in-house stable value investment fund in the bank’s $44 billion 401(k) plan performed poorly when compared with other available similar funds, JP Morgan Chase is now disputing allegations of mismanagement in the employees’ retirement plan, stating that this allegation rests on a “false premise,” in a motion filed last week.

This new lawsuit was filed one day after JPMorgan was  hit with an ERISA lawsuit  over its employee health plan. Current and former employees are suing JPMorgan, alleging that it allows inflated drug prices through its partnership with its pharmacy benefit manager, CVS Caremark. Employees claim that the bank’s failure to properly oversee its PBM contract resulted in unnecessarily high prescription drug costs.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.